Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Accumulated Expenses: 2011-2018

Historic Accumulated Expenses for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Jun 2018 value amounting to $3.7 million.

  • EyePoint Pharmaceuticals' Accumulated Expenses fell 9.05% to $2.9 million in Q1 2019 from the same period last year, while for Mar 2019 it was $2.9 million, marking a year-over-year decrease of 9.05%. This contributed to the annual value of $3.7 million for FY2018, which is 11.86% down from last year.
  • As of FY2018, EyePoint Pharmaceuticals' Accumulated Expenses stood at $3.7 million, which was down 11.86% from $4.2 million recorded in FY2017.
  • Over the past 5 years, EyePoint Pharmaceuticals' Accumulated Expenses peaked at $4.2 million during FY2017, and registered a low of $1.5 million during FY2014.
  • For the 3-year period, EyePoint Pharmaceuticals' Accumulated Expenses averaged around $3.8 million, with its median value being $3.7 million (2018).
  • As far as peak fluctuations go, EyePoint Pharmaceuticals' Accumulated Expenses declined by 19.54% in 2014, and later surged by 68.70% in 2015.
  • Yearly analysis of 5 years shows EyePoint Pharmaceuticals' Accumulated Expenses stood at $1.5 million in 2014, then surged by 68.70% to $2.6 million in 2015, then surged by 39.36% to $3.6 million in 2016, then grew by 17.89% to $4.2 million in 2017, then dropped by 11.86% to $3.7 million in 2018.